ALL COMPANIES

Novolin R is an insulin receptor agonist, administered via an intranasal route to enhance insulin signaling in the brain. Insulin...

ISN-GSH (insulin-glutathione) is a combination of insulin receptor agonist activity and a reducing agent (glutathione), aimed at improving both insulin...

Idebenone is a small molecule reducing agent. It works by decreasing oxidative stress in the brain, which is a key...

Exenatide is a peptide that functions as a GLP-1 agonist (glucagon-like peptide-1 agonist). GLP-1 agonists help regulate glucose metabolism and...

Liraglutide is a GLP-1 agonist that acts as a peptide therapeutic. Like exenatide, liraglutide is believed to have neuroprotective properties,...

Semaglutide is a peptide that acts as a GLP-1 agonist, similar to the other therapies in this list. It is...

Lixisenatide is a peptide GLP-1 agonist, working in the same pathway as exenatide and liraglutide. It is being investigated for...

NLY-01 is a peptide and a GLP-1 agonist, specifically a pegylated exenatide. Pegylation increases the stability and half-life of the...

PT-320 is a sustained-release form of exenatide (exenatide SR), a GLP-1 agonist in peptide form. The sustained-release formulation ensures longer-lasting...